CRBN and Miyoshi myopathy: Recently, a novel truncating mutation and R283K point mutation of CRBN were observed in an extramedullary plasmacytoma from a MM patient with clinical resistance to lenalidomide, which is, however, a rare event (4 %) in MM patients [33].